Acute pulmonary embolism: endovascular therapy

Stephen P. Reis, Ken Zhao, Noor Ahmad, Reginald S. Widemon, Christopher W. Root, Seth M. Toomay, James M. Horowitz, Akhilesh K. Sista


Pulmonary embolism (PE) is a leading cause of morbidity and mortality worldwide. PE is a complex disease with a highly variable presentation and the available treatment options for PE are expanding rapidly. Anticoagulation (AC), systemic lysis, surgery, and catheter-directed thrombolysis (CDT) play important roles in treating patients with PE. Thus, a multidisciplinary approach to diagnosis, risk stratification, and therapy is required to determine which treatment option is best for a given patient with this complex disease.